Ads
    Related conference
  1. QSAR of acyl alizarin red biocompound derivatives of Rubia tinctorum roots and its ADMET properties as anti-breast cancer candidates against MMP-9 protein receptor: In Silico study
  2. Oxadiazole derivatives as potential egfr protein kinase inhibitors: prediction of in-silico admet properties and molecular docking study
  3. QSAR Modeling, Molecular Docking, and ADME Studies of Novel 5-Oxo- Imidazoline Derivatives as Anti-Breast Cancer Drug Compounds against MCF-7 Cell Line
  4. Examining the expression of low-density lipoprotein receptor (LDLR) and low-density lipoprotein receptor-related protein 6 (LRP6) genes in breast cancer cell lines
  5. In Silico Computational Prediction of Anti-Breast Cancer Effect of Abruquinones from Abrus precatorius L
  6. In silico investigation of lactoferrin protein characterizations for the prediction of anti-microbial properties
  7. Pharmacokinetics Studies of some Diaryl Pyrimidinamine Derivatives as Anti-Cancer Agent: In-Silico Drug Design and Molecular Docking
  8. In-Silico ADMET Prediction, Structure-Based Drug Design and Molecular Docking Studies of Quinazoline Derivatives as Novel EGFR Inhibitors
  9. Qsar and Docking Studies of New Triazolopiperazine Derivatives as Potent Hypoglycemic Candidates
  10. A REVIEW OF BREAST CANCER TREATMENT MODALITIES IN UGANDA : AN APPRAISAL OF THE BREAST CANCER DIAGNOSTIC PROCESS, REGULATORY APPROVAL AND SUPPLY SYSTEM OF STANDARDIZED ANTI-BREAST CANCER MEDICINES